Search

29 Dec 2004: Since K-252a is a much more potent kinase inhibitor than H-9, and some non- specific effects were noted at concentrations of H-9 in excess of 200 pM, most ... Aliquots of cpt-CAMP-treated cells were further treated for 10 min with K-252a (20 PM) or H-9

3 Dec 2004: interactions. J. Cell Biol. 155, 193–200 (2001). 20. Zhang, B. et al.

4 May 2004: 510 100 1;0 200 2;0 310 3;0 400 4 ; 0 500.

10 Mar 2004: 171 3 203 4 110 29 46 27 64 32Unknown 864 8 429 8 435 8 151 17 91 21 60 14White 8,592 78 4,200 77 4,392 79

30 Jun 2004: Spo0J] (mM)0 25 50 100 200 300 25 50 100 200 300. ... The protein was buffer exchanged into20 mM Tris, pH 8.5, 200 mM NaCl using a Sephadex G25 gelfiltration column (Amersham).

26 May 2004: 62. 1)0. 0(6. 2.1). F. rom. 200. 4–05. inco. rpor. ated. ... 58.2. 185. 213. 2.4. 60.3. 192. 713. 7.7. 62.5. 200. 3.

24 Sep 2004: The high-spin. Acknowledgmentssupernatant was loaded in batch onto Glutathione Sepharose4B.The resin was washed with buffer B (50 mM Tris [pH 7.5] and 200.

21 Sep 2004: MR A. PLEKHANOVS100 ClassesS402 Classes. Subject 200: MacroeconomicsCourse Co-ordinator: Mr K.

6 Oct 2004: indicated dishes were treated with 200 nM wortmannin 40 minRap on ARAP3 Rho GAP activity (Figure 3C).

12 Jan 2004: 13,200 1Biorobotics Ltd 22,223 3Biosynergy Ltd 16,387 1Biotica Technology Ltd 10,685 1BOC Group Plc 30,278 1Boreas Consultants Ltd 8,368 2BP 15,991 3British American Tobacco ... Wellcome 10,063 1Cambridge Neuroscience Inc 7,480 1Carnegie Corporation of